Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GEMoaB GmbH is a privately-owned, clinical-stage biopharmaceutical company based in Dresden, Germany, that is focused on becoming a leading, fully integrated biopharmaceutical company. By focusing on our proprietary next generation UniCAR, RevCAR and ATAC platforms, we intend to discover, develop, manufacture and commercialize next generation immunotherapies for the treatment of cancer patients with a high unmet medical need.

List your booth number for exhibitions, ask us